Chronic autoimmune atrophic gastritis associated with primary hyperparathyroidism: A transversal prospective study

European Journal of Endocrinology

Volumn 168, Issue 5, 2013, Pages 755-761

  Massironi, Sara ^a   Cavalcoli, Federica ^a,b   Rossi, Roberta Elisa ^a,b   Conte, Dario ^a,b   Spampatti, Matilde Pia ^a,b   Ciafardini, Clorinda ^a,b   Verga, Uberta ^a,b   Beck Peccoz, Paolo ^a,b   Peracchi, Maddalena ^b  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; CALCIUM ION; CHROMOGRANIN A; GASTRIN; PARATHYROID HORMONE;

ADULT; AGED; ARTICLE; ATROPHIC GASTRITIS; AUTOIMMUNE DISEASE; CALCIUM BLOOD LEVEL; CHRONIC AUTOIMMUNE ATROPHIC GASTRITIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GASTRIN BLOOD LEVEL; GASTROINTESTINAL ENDOSCOPY; HUMAN; HYPERGASTRINEMIA; MAJOR CLINICAL STUDY; MALE; PARATHYROID HORMONE BLOOD LEVEL; PREVALENCE; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SECONDARY HYPERPARATHYROIDISM; VITAMIN D DEFICIENCY;

ADULT; AGED; AUTOIMMUNE DISEASES; CALCIUM; COMORBIDITY; FEMALE; GASTRITIS, ATROPHIC; HUMANS; HYPERPARATHYROIDISM, PRIMARY; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; VITAMIN D;

EID: 84877141854     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-12-1067     Document Type: Article

References (45)

1. Toh BH, van Driel IR & Gleeson PA. Pernicious anemia. New England Journal of Medicine 1997 337 1441-1448. (doi:10.1056/ NEJM199711133372007)
2. Solcia E, Bordi C, Creutzfeldt W., Dayal Y, Dayan AD, Falkmer S, Grimelius L & Havu N. Histopathological classification of nonantral gastric endocrine growths in man. Digestion 1988 41 185-200. (doi:10.1159/000199786)
3. Tozzoli R, Kodermaz G, Perosa A.R., Tampoia M., Zucano A, Antico A & Bizzaro N. Autoantibodies to parietal cells as predictors of atrophic body gastritis: a five-year prospective study in patients with autoimmune thyroid diseases. Autoimmunity Reviews 2010 10 80-83. (doi:10.1016/j.autrev.2010.08.006)
4. De Block CEM, De Leeuw IH & Van Gaal LF. Autoimmune gastritis in type 1 diabetes: a clinically oriented review. Journal of Clinical Endocrinology and Metabolism 2008 93 363-371. (doi:10.1210/ jc.2007-2134)
5. Betterle C & Zanchetta R. Update on autoimmune polyendocrine syndromes (APS). Acta Bio-Medica: Atenei Parmensis 2003 74 9-33.
6. Mazeh H, Sippel RS & Chen H. The role of gender in primary hyperparathyroidism: same disease, different presentation. Annals of Surgical Oncology 2012 19 2958-2962. (doi:10.1245/s10434-012-2378-3)
7. Lundgren E. Primary hyperparathyroidism of postmenopausal women. Upsala Journal of Medical Sciences 1999 104 87-130. (doi:10.3109/03009739 909178956)
8. Olin R., Thyrotoxicosis, pernicious anemia. hypertension and primary hyperparathyroidism. Minnesota Medicine 1977 60 478-481.
9. Bernades P, Nataf C, Courreges JP & Merceron RE. Hypergas- trinémie secondaire à une achlorhydrie au cours de l'hyperpar-athyroïdie primaire. Deux observations. La Nouvelle Presse Médicale 1978 7 3461.
10. De Vega Santos T, Zamarrón Moreno A, Pascual de Pablo E & López López C. Anemia perniciosa e hiperparatiroidismo primario. Revista Clínica Española 1995 195 200-201.
11. Selking O, Borch K, Johansson H., Ljunghall S & Wide L. Evaluation of parathyroid function in patients with hypergas-trinaemia and pernicious anaemia. Upsala Journal of Medical Sciences 1982 87 215-222. (doi:10.3109/030097382091 78426)
12. Primrose JN & Joffe SN. Hyperparathyroidism and hypergastrinemia revisited. Surgery 1984 96 1144-1150.
13. Corleto VD, Minisola S, Moretti A., Damiani C, Grossi C, Ciardi S., D'Ambra G, Bordi C, Strom R, Spagna G et al. Prevalence and causes of hypergastrinemia in primary hyperparathyroidism: a prospective study. Journal of Clinical Endocrinology and Metabolism 1999 84 4554-4558. (doi:10.1210/jc.84.12. 4554)
14. Peracchi M, Gebbia C, Basilisco G., Quatrini M, Tarantino C, Vescarelli C., Massironi S & Conte D. Plasma chromogranin A in patients with autoimmune chronic atrophic gastritis, enterochro-maffin-like cell lesions and gastric carcinoids. European Journal of Endocrinology 2005 152 443-448. (doi:10.1530/eje.1.01862)
15. Adami S, Marcocci C & Gatti D. Epidemiology of primary hyper-parathyroidism in Europe. Journal of Bone and Mineral Research 2002 17 18-32.
16. Yeh MW, Wiseman JE, Ituarte P.H., Pasternak JD, Hwang RS, Wu B, Liu IL & Haigh PI. Surgery for primary hyperparathyroidism: are the consensus guidelines being followed? Annals of Surgery 2012 256 1179-1183. (doi:10.1097/SLA.0b013e31824dad7d)
17. Thomas D, Alexandraki K, Nikolaou A., Antoniou S, Kanakis G, Zilos A., Sougioultzis S & Kaltsas G. Primary hyperparathyroidism in patients with gastric carcinoid tumors type 1: an unusual coexistence. Neuroendocrinology 2010 92 252-258. (doi:10.1159/ 000320940)
18. Alberti-Flor J.J., Halter S & Dunn GD. Multiple gastric carcinoids in a patient with a history of primary hyperparathyroidism. American Journal of Gastroenterology 1985 80 531-534.
19. Rode J, Dhillon AP, Cotton P.B., Woolf A & O'Riordan JL. Carcinoid tumour of stomach and primary hyperparathyroidism: a new association. Journal of Clinical Pathology 1987 40 546-551. (doi:10.1136/jcp.40.5.546)
20. Nores JM. Gastric carcinoid tumor and parathyroid adenoma. Gut 1988 80 531-534. (doi:10.1136/gut.29.5.689)
21. Ollenschläger G., Reincke M, Steffen M & Allolio B. Unerkannter primärer Hyperparathyreoidismus bei gleichzeitigem Vorliegen eines insulinpflichtigen Diabetes mellitus. Medizinische Klinik 1988 83 844-854.
22. Corleto VD, Goebel SU, Panzuto F, Jensen R.T. Delle Fave G & Annibale B. Co-existence of hyperparathyroidism, hypergastrine-mia and multiple gastric carcinoids is not always due to incomplete expression of the MEN-1 syndrome. Digestive and Liver Disease 2003 35 585-589. (doi:10.1016/S1590-8658(03) 00278-0)
23. Christopoulos C, Balatsos V, Rotas E., Karoumpalis I, Papavasileiou D, Kontogeorgos G., Dupasquier S, Calender A, Skandalis N & Economopoulos P. The syndrome of gastric carcinoid and hyperparathyroidism: a family study and literature review. European Journal of Endocrinology 2009 160 689-694. (doi:10.1530/EJE-08-0867)
24. Dixon MF, Genta RM, Yardley JH & Correa P. Classification and grading of gastritis. American Journal of Surgical Pathology 1996 20 1161-1181. (doi:10.1097/00000478-199610000-00001)
25. Marcocci C & Cetani F. Clinical practice. Primary hyperparathyroidism. New England Journal of Medicine 2011 365 2389-2397. (doi:10.1056/NEJMcp1106636)
26. Fujimori M, Ikeda S, Shimizu Y., Okajima M & Asahara T. Accumulation of b-catenin protein and mutations in exon 3 of b-catenin gene in gastrointestinal carcinoid tumor. Cancer Research 2011 61 6656-6659. (doi:10.1136/gut.29.5.689)
27. Bjorklund P, Linddberg D, Akerstrom G & Westin G. Stabilizing mutation of CTNNB1/b-catenin and protein accumulation analyzed in a large series of parathyroid tumors of Swedish patients. Molecular Cancer 2008 7 53. (doi:10.1186/1476-4598-7-53)
28. Hervieu V, Lepinasse F, Gouysse G., Guillaud O, Barel C, Chambonniere M.L., Bringuier PP, Poncet G, Lombard-Bohas C, Partensky C et al. Expression of b-catenin in gastroenteropancrea-tic endocrine tumors: a study of 229 cases. Journal of Clinical Pathology 2006 59 1300-1304. (doi:10.1136/jcp.2005.035097)
29. Costa-Guda J & Arnold A. Absence of stabilizing mutations of b-catenin encoded by CTNNB1 exon 3 in a large series of sporadic parathyroid adenomas. Journal of Clinical Endocrinology and Metabolism 2007 92 1564-1566. (doi:10.1210/jc.2006-2554)
30. Erickson LA, Jin L, Wollan P., Thompson GB, van Heerden JA & Lloyd RV. Parathyroid hyperplasia, adenomas, and carcinomas: differential expression of p27Kip1 protein. American Journal of Surgical Pathology 1999 23 288-295. (doi:10.1097/00000478-199903000-00007)
31. Doganavsargil B, Sarsik B, Kirdok F.S., Musoglu A & Tuncyurek M. p21 and p27 immunoexpression in gastric well-differentiated endocrine tumors (ECL-cell carcinoids). World Journal of Gastro-enterology 2006 12 6280-6284.
32. Barreras RF. Calcium and gastric secretion. Gastroenterology 1973 64 1168-1184.
33. Zaniewski M, Jordan PH & Yip B. Serum gastrin level is increased by chronic hypercalcemia of parathyroid or non-parathyroid origin. Archives of Internal Medicine 1986 146 478-482. (doi:10.1001/archinte.1986.00360150076009)
34. Reeder DD, Jackson BM, Ban J.L., Clendinnen BG, Davidson WD & Thompson JC. Influence of hypercalcemia on gastric acid secretion in man. Annals of Surgery 1970 172 540-544. (doi:10.1097/ 00000658-197010000-00002)
35. Wilson SD, Singh RB & Kalkhoff RK. Does hyperparathyroidism cause hypergastrinemia? Surgery 1976 80 231-237.
36. Bjerneroth G, Juhlin C, Gudmundsson S., Rastad J. Akerström G & Klareskog L. Major histocompatibility complex class II expression and parathyroid autoantibodies in primary hyperparathyroidism. Surgery 1998 124 503-509. (doi:10.1016/S0039-6060(98) 70096-0)
37. Charrié A, Chikh K, Peix JL, Berger N, Decaussin M, Veber S, Bienvenu J, Lifante JC & Fabien N. Calcium-sensing receptor autoantibodies in primary hyperparathyroidism. Clinica Chimica Acta 2009 406 94-97. (doi:10.1016/j.cca.2009.05.023)
38. Pelletier-Morel L., Fabien N, Mouhoub Y., Boitard C & Larger E. Hyperparathyroidism in a patient with autoimmune poly-glandular syndrome. Internal Medicine 2008 47 1911-1915. (doi:10.2169/internalmedicine.47.1355)
39. Ginde AA, Wolfe P, Camargo CA Jr & Schwartz RS. Defining vitamin D status by secondary hyperparathyroidism in the U.S. population. Journal of Endocrinological Investigation 2012 35 42-48. (doi:10.3275/7742)
40. Sipponen P & Härkönen M. Hypochlorhydric stomach: a risk condition for calcium malabsorption and osteoporosis? Scandinavian Journal of Gastroenterology 2010 45 133-138. (doi:10.3109/ 00365520903434117)
41. Ali T, Roberts DN & Tierney WM. Long-term safety concerns with proton pump inhibitors. American Journal of Medicine 2009 122 896-903. (doi:10.1016/j.amjmed.2009.04.014)
42. Penna G & Adorini L. 1a, 25-Dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. Journal of Immunology 2000 164 2405-2411.
43. Chen S, Sims GP, Chen X.X., Gu YY, Chen S & Lipsky PE. Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. Journal of Immunology 2007 179 1634-1647.
44. Boonstra A, Barrat FJ, Crain C, Heath V.L., Savelkoul HF & O'Garra A. Journal of Immunology 2001 167 4974-4980.
45. Antico A, Tozzoli R, Giavarina D., Tonutti E & Bizzaro N. Hypovitaminosis D as predisposing factor for atrophic type A gastritis: a case-control study and review of the literature on the interaction of Vitamin D with the immune system. Clinical Reviews in Allergy & Immunology 2012 42 355-364. (doi:10.1007/ s12016-011-8255-1)